title: Response to intravenous immunoglobulin predicts splenectomy response in children with immune thrombocytopenic purpura.
abstract: OBJECTIVE
  Response to intravenous immunoglobulin (IVIG) has been shown to predict response to splenectomy in adults with immune thrombocytopenic purpura (ITP). However, reports in children have been inconsistent. We sought to determine whether response to IVIG is predictive of response to splenectomy in children.
  
  
  METHODS
  Thirty-two assessable children were identified by a retrospective chart review. Response was graded according to previously published criteria as follows: "excellent" (platelets >150 000 within 1 week), "good" (platelets between 50 000 and 150 000), and "poor" (platelets <50 000). "Response" refers to both splenectomy and IVIG, and response to splenectomy was counted only when it was durable.
  
  
  RESULTS
  Twenty-one of 23 patients who had a good or excellent response to IVIG also had an excellent response to splenectomy. Six of 9 patients who had a poor response to IVIG also had a poor response to splenectomy. Response to IVIG was a sensitive predictor of response to splenectomy in 88% of patients. Response to IVIG had a specificity of 75%, a positive predictive value of 91%, and a negative predictive value of 67%. Response to prednisone and length of time to splenectomy were not correlated with splenectomy response.
  
  
  CONCLUSIONS
  These results suggest that response to IVIG is predictive of response to splenectomy in children with chronic ITP. This correlation may be of value in deciding whether a splenectomy should be performed in children with chronic ITP.
authors.affiliation: Department of Oncological Sciences, University of Utah School of Medicine, Salt Lake City Utah, USA.
authors.forename: Derick
authors.initials: D
authors.lastname: Holt
authors.forename: Justin
authors.initials: J
authors.lastname: Brown
authors.forename: Kelly
authors.initials: K
authors.lastname: Terrill
authors.forename: Robert
authors.initials: R
authors.lastname: Goldsby
authors.forename: Rebecka L
authors.initials: RL
authors.lastname: Meyers
authors.forename: Jody
authors.initials: J
authors.lastname: Heximer
authors.forename: Beth
authors.initials: B
authors.lastname: Nordfors
authors.forename: William B
authors.initials: WB
authors.lastname: Slayton
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage* / Q000276:immunology; D007223:Infant; D008297:Male; D011237:Predictive Value of Tests; D011300:Preoperative Care; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy* / Q000276:immunology / Q000601:surgery*; D012189:Retrospective Studies; D012680:Sensitivity and Specificity; D013156:Splenectomy / Q000706:statistics & numerical data*; D016896:Treatment Outcome
chemical_list: D016756:Immunoglobulins, Intravenous